1. Singh TP, Amorim CF, Lovins VM, Bradley CW, Carvalho LP, Carvalho EM, Grice EA, Scott P. Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis. Journal of Experimental Medicine. 2023;220(12):e20230558.
https://doi.org/10.1084/jem.20230558
2. Singh TP, Carvalho AM, Sacramento LA, Grice EA, Scott P. Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis. PLOS Pathogens. 2021;17(10):e1009693.
https://doi.org/10.1371/journal.ppat.1009693
3. Farias Amorim C, Lovins VM, Singh TP, Novais FO, Harris JC, Lago AS, Carvalho LP, Carvalho EM, Beiting DP, Scott P, Grice EA. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity. Science Translational Medicine. 2023;15(718):eadh1469.
https://doi.org/10.1126/scitranslmed.adh1469
4. Singh TP, Zhang HH, Borek I, Wolf P, Hedrick MN, Singh SP, Kelsall BL, Clausen BE, Farber JM. Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation. Nature Communications. 2016;7:13581.
https://doi.org/10.1038/ncomms13581
5. Singh TP, Vieyra-Garcia PA, Wagner K, Penninger J, Wolf P. Cbl-b deficiency provides protection against UVB-induced skin damage by modulating inflammatory gene signature. Cell Death & Disease. 2018;9:835.
https://doi.org/10.1038/s41419-018-0858-5
6. Singh TP, Schön MP, Wallbrecht K, Michaelis K, Rinner B, Mayer G, Schmidbauer U, Strohmaier H, Wang XJ, Wolf P. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. The Journal of Immunology. 2010;184(12):7257–7267.
https://doi.org/10.4049/jimmunol.0903719
View all publications on PubMed